Authors Posts by Dr. Judy Blume

Dr. Judy Blume


By now you might have become aware of your status as an Empath. But do you know that you are a starseed? Do you know that you came on this Earth with a mission and absolute resolve and faith that you will succeed in that mission? And yet, something is holding you back and it is fear.

The problem is, this is not your own fear; this is the fear of the people around you which you naturally pick on. You are a starseed, you don’t have any notion of fear, but you are in a society which is riddled with fears and uncertainties and it is only natural that you will get affected as well.

So when you pick on the fears of others, you need to recognize it for what it is and this expel it. Every time you feel sigh feelings which are not natural to you or not concurrent to your own truth, think about your surroundings, think who’s in your proximity and is it perhaps that you are reading their emotions as your own.

Being an empath it is only natural that you want to help and take away the fears of others, but you can’t dump then onto yourself. Moreover people need to get over their own negativity by themselves otherwise they’d never learn how to escape it and find positivity.

You know what’s your life’s mission and you are on your way to achieve it. You know you need to get rid of old karma and toxins that weigh you down. And you are slowly cleansing yourself, your physical as well as mental and emotional self. You are aware of your light, which will help you overcome all these troubles and successfully complete your assignment here on Earth and you are getting as close to it as possible.

When feelings of regret and failure from your past life threaten to overwhelm you, remember they are only there because you are in the process of ejecting them forever. Always remember that you are in the process of relieving yourself of all these toxins and anytime anything gets too overwhelming for you, focus on expelling it from your consciousness.

Every time you find yourself harboring emotions which are not your own, like fear, you need to face them and let them go. You have many things of your own to worry about; you don’t need to take care of the fear of others as well. You are here to help and heal the world but you won’t do it by taking their burden on your own shoulders. You need to find your own light so that you can illuminate the path for others. That’s how you help them, that is your life’s mission.

As I mentioned before, if you take away their feelings of fear and inadequacy, you are not only harboring negativity which is not your own, you are also depriving them of a much needed lesson. Learn to cleanse yourself of these emotions and then you can teach others how to do so as well. You need to stop letting the emotions of others hold you back. You are the conqueror and nothing can keep you down, let your light reach you and cleanse you so that you can defeat all that stands in the way of you and your mission.

Treatment For Fibromyalgia

Treatment For Fibromyalgia much like treatments for any and all disease., often starts with the management of symptoms. With this disorder, the symptoms create a string of tender points along the body. Coupling this with extreme fatigue and an inability to sleep and you have a concoction for a drastically poor quality of life riddled with pain and discomfort.

Medical Cannabis Treatment for Fibromyalgia

The prevalence of Treatment For Fibromyalgia goes up as a person ages, yet 80-90% of all cases are women. The symptoms are known to worsen with persistence as it progresses and it is worsened by the weather, illness and stress. One cannabinoid profile that is well suited for this disorder patients has been identified as CBD. It is suggested patients obtain CBD rich medicine.  Synergistically coupling a cbd rich oil with one that contains Low THC, there is additional relief provided to patients.

According to a report conducted by the National Pain Foundation and National Pain Report, medical cannabis has been rated as one of the most effective treatment in reducing pain from Fibromyalgia.Many of the 1,300 fibromyalgia patients who responded to the survey said they had tried all 3 of the FDA approved drugs. One patient explained there were far more negative side effects to the FDA approved drugs than there were positive attributes.

When asked about the effectiveness of  Cymbalta (Duloxetine), 60% of those who tried the medication stated that it did not work for them, whilst 8% reported it to be very effective. 32% reported Cymbalta helped slightly.Of those in the study who tried Pfizer’s Lyrica (Pregabalin) a whopping 61% reported that there was no relief. 10% reported Lyrica to be very effective whilst 29% said it helped slightly.

Rating Forest Laboratories’ Savella (Milnacipran), 68% of those trailing the drug stated that it didn’t work. 10% reported that it was very effective and 22% reported slight relief.

Comparing the study findings against those who had tried medical cannabis for their this disorder symptoms 62% said it was very effective. Another 33% said it helped slightly whilst only 5% reported no relief.

Never before has consuming cannabis been so safe. Yet, the FDA and DEA still hate it. Here’s why.
Cannabis is safer than it has ever been. Currently, thanks to the herb’s status as a schedule 1 controlled substance, there are no national quality control standards for cannabis. However, the cannabis industry and individual states have stepped up to fill the gap. To meet consumer demand for safe, healthy products, herb lovers can now choose from a wide variety of products that drastically improve the safety of cannabis consumption. Yet, even though weed is safer than ever, the Food and Drug Administration still hate it.

Weed is safer than ever

pax Weed Is Safer Than Ever... And The FDA Hates It
Photo credit

A quick browse on will show you that cannabis technology is more advanced than ever. Here, consumers can browse through hundreds of different products, all designed to improve the overall cannabis experience and make it safer.

Dozens of brands have entered the cannabis scene, all seeking to fill gaps in the burgeoning market for cannabis consumer products.

Unlike smoking cannabis, which forces you to inhale hot, burning embers and hash smoke, vaporizers heat the herb just enough to melt tasty trichomes and transform them into a safe steam.

Convection vaporizers, like the Firefly 2, use hot air to gently toast the herb and create a truly smooth and clean vapor. This clean technology saves your lungs from irritation and the potential carcinogens in smoke.

The boom in safe vapor technology isn’t the only way the industry is self-managing quality control and consumer safety right now. States with legal recreational cannabis have implemented strict quality control standards that ensure that cannabis buds do not contain unsafe levels of pesticides, molds, and residual solvents.

Different varieties of cannabis are also available, including strains which do not cause the traditional psychoactive “high”, the source of the major concerns for many policy makers and canna skeptics.

Thanks to the internet, people are also more educated than ever before on the safeways to use cannabis and the plant’s many components.

FDA still hates cannabis

Weed Is Safer 2 Weed Is Safer Than Ever... And The FDA Hates It
Photo credit

Though the cannabis industry has done wonders to improve the consumer safety of cannabis without the FDA’s help, the institution has a historical record of overlooking the herb’s safety profile and medicinal value.

In August of 2016, the Drug Enforcement Administration (DEA) issued statementsexplaining that cannabis would continue to be classified as a Schedule 1 drug, which bars medical research on the plant.

The DEA’s stance was informed by recommendations released by the FDA a year earlier, which were not made public. VICE News obtained exclusive copies of these previously unpublished reports and released them to the public online.

Back in 2015, the Department of Health and Human Services declared that cannabis should remain a Schedule 1 Drug under the Controlled Substances Act of 1970.

According to one document, the National Institute on Drug Abuse (NIDA) concurs with this recommendation, though the document suggested that the government be more open to researching the plant.

Cannabis is currently the only Schedule 1 Controlled Substance that requires Public Health Service review and approval is required.

The documents show that the FDA found no firm evidence that cannabis contributes to cancer, lower IQ, or mental illness. However, they did express concern over the popularity of the herb and the fact that people choose to smoke it rather than take it in pill form, among a few other things.

This recommendation comes after four states had already legalized recreational cannabis. A year later, in November of 2016, that number doubled to eight.

Over half of all U.S. states plus Washington D.C. have some form of medical cannabis policy. Federal law and the efforts of the American public and individual states seem to be at odds with each other.

Fortunately, however, where there is demand for safe access, local lawmakers and innovative cannabis businesses are popping up to fill the need. Entrepreneurial ventures like Namaste Vapes seeks to connect the public with the education and safe consumption methods that should be supported by the federal government.


Marijuana Legalization is not going well at the United Nations

Why Is The United Nations Warning Members States Against Recreational Cannabis?

The United Nations’ International Narcotics Control Board (INCB), the organization’s drug enforcement body, warned international leaders of its member states to make sure cannabis stays illegal.

Its 2017 annual report contains strict warnings to ensure that cannabis remains illegal. However, the INCB is made up of individuals, not UN member states, as a means of avoiding political pressure.

What’s fishy is that the Board members are required to have “medical, pharmacological or pharmaceutical experience,” which arose out of efforts from Big Pharma which lobbied against legalization. Even if UN rules state that non-medical use of cannabis should be illegal based on (outdated) international drug control treaties that were agreed on years ago, many member states including Canada and the United States continue to legalize the herb.

“Governments and jurisdictions in North America have continued to pursue policies with respect to the legalization of the use of cannabis for non-medical purposes, in violation of the 1961 Convention as amended,” the INCB wrote in their report, which was released last week.

The INCB called out several countries in the report. For one, Canada – saying that the proposed cannabis legalization law that will be finalized sometime later this year is in “contravention” of the agreements.

“The Board notes with concern that Canada, draft legislation intended to authorize and regulate the nonmedical consumption of cannabis was introduced in the House of Commons in April 2017,” says the report. “As the Board has stated repeatedly, if passed into law, provisions of Bill C-45, which permit non-medical and non-scientific use of cannabis would be incompatible with the obligations assumed by Canada under the 1961 Convention as amended.”

They also went after Uruguay, which legalized cannabis in 2013, saying that it was in “clear violation” of the drug treaties.

“The limitation of the use of controlled substances to medicinal and scientific purposes is a fundamental principle to which no derogation is permitted under the 1961 Convention as amended,” the INCB wrote.

The INCB also slammed Jamaica, where the religion allows the use of cannabis. Jamaica legalized cannabis in 2015 for religious purposes. “The Board reminds the Government of Jamaica and all other parties that under article 4, paragraph (c), of the 1961 Convention as amended only the medical and scientific use of cannabis is authorized and that for any other purposes, including religious, is not permitted,” the report writes.

They didn’t miss out on the United States, either. The report wrote that the North American policies on cannabis legalization made it easy for drug trafficking. “The situation pertaining to cannabis cultivation and trafficking in North America continues to be in flux, owing to the widening scope of personal non-medical use schemes in force in certain constituent states of the United States,” the INCB report writes. “The decriminalization of cannabis has apparently led organized criminal groups to focus on manufacturing and trafficking other illegal drugs, such as heroin.”

Even though the report says that medical cannabis is allowed based on international conventions, they don’t want member states to expand to recreational cannabis to “ensure that cannabis is prescribed by competent medical practitioners according to sound medical practice, and based on sound scientific evidence.”

Additionally, the INCB says that medical cannabis patients aren’t allowed to grow the plant for their own use. It seems that their issues with cultivation lies in being able to regain control of the population. “States must take measures to prohibit the unauthorized cultivation of cannabis plants, to seize and destroy illicit crops, and to prevent the misuse of and trafficking in cannabis. Similarly, the Board wishes to draw the attention of all Governments to its previously stated position that personal cultivation of cannabis for medical purposes is inconsistent with the 1961 Convention as amended because, inter alia, it heightens the risk of diversion,” the report says.

Should we have anything to worry about? Likely not. Even if the INCB is merely a puppet of Big Pharma, they usually don’t have much more power to do much aside from issuing warnings. So even if their latest report is filled with strict warnings, they won’t do much to stop the current efforts to legalize cannabis in member states.

In the video “Cured: A Cannabis Story,” cancer patient David Triplett tells the tale of how he used cannabis oil to cure his skin cancer.

Triplett had previously had two lesions removed from the tip of his nose, but the cancer returned in 2009. His doctor prescribed a Fluorouracil cream to apply all over his face and neck. However, Triplett did some research and learned that Fluorouracil is a form of chemotherapy that has alarming side effects, including burning, redness and inflammation of the skin in the areas where it is applied.

Instead of subjecting himself to the side effects, he looked for an alternative solution and soon learned about the anti-tumor effects of cannabis. He watched the Rick Simpson video “Run from the Cure” about treating cancer with hemp oil, and learned that marijuana derivatives were being used in research to treat breast cancer, prostate cancer, lymphoma, leukemia and other variations of the pernicious disease.

Triplett was amazed at the amount of evidence he uncovered, such as testimony from professionals like Dr. Lester Grinspoon (who admitted he had been brainwashed against marijuana despite his medical and scientific training) and a study out of Brown University that found long-term cannabis users are 62 percent less likely to develop head and neck cancers.

Triplett was convinced that he should give cannabis a try. Fortunately, he lives in California, where medical marijuana is legal under state law, so he was able to purchase cannabis oil from a local dispensary. After he applied the oil to his lesions for three to four weeks, he saw dramatic results. “Not only was the oil healingmy nose, it was bringing cancer to the surface that I didn’t even know was there,” he says.

Through a series of photos, Triplett documents the oil curing the blemishes on his nose and drawing new ones out of the skin until he was finally free of lesions.

“Once I realized that the hash oil had cured my cancer, I began to ask myself some questions,” says Triplett.  “Why hadn’t my doctor heard about this? Why hadn’t I heard about this?”

He came to discover the problem was in profit and politics. If drug companies can’t make enough money from the medicine, they don’t bother to spend resources to study it. Cannabis oil isn’t patented so its potential for profit is low.

Triplett then displays a series of old cannabis medicines that used to be legal and widespread before it was prohibited by states and the federal government starting in the 1920s. “This medicine was taken away from us and now people are needlessly dying,” he says.

It’s taken decades of evidence and work to even begin to undo the damage of prohibition. Triplett notes that the National Cancer Institute, the American Cancer Society and members of our government have known since 1975 that cannabis cures cancer, citing a study from that year that showed certain marijuana derivatives could halt tumors in the lungs. Only recently did the National Institute of Drug Abuse acknowledge the promise of cannabis in the fight against cancer, and the plant remains banned under Schedule I of the federal Controlled Substances Act, categorized as a drug with no medical value.

“If cannabis cures cancer, why would it be illegal?” Triplett asks. “All we want to do is heal ourselves, and there’s shouldn’t be a law against that.”


In a backpacking hostel during a stag weekend 10 years ago, I fell asleep on a top bunk next to an open window. Of course, that now strikes me as a stupid thing to have done, but at the time I didn’t give it a thought. I was on a weekend away, not a health-and-safety awareness course. At some point during the night, I tried getting out of the bunk, but instead of turning left and using the ladder, I turned right and hopped straight out of the window.

I fell 24ft on to concrete. From a survival point of view, I was lucky to land on my feet. The downside was that some rather important sections of my legs did not come out of it so well.

My left heel was crushed, while over on the right, my tibia and fibula – the two long bones in the lower leg – detached from their couplings and shattered. The next few weeks involved operations, plates, screws and quite unimaginable levels of agony. At one point, I felt a kind of blinding calm, as though the pain had gone all the way up the scale and rung a bell at the top.

While those pain levels have never returned, over the years there have been generous helpings of it; my legs didn’t take too kindly to being smashed up and bolted back together, and they seem to enjoy reminding me of this. After trying many different ways of managing the pain, eight months ago I started taking cannabidiol, or CBD for short – a non-psychoactive compound found in both hemp and cannabis plants.

The effect on the pain has been profound. It comes as an oil that I put under my tongue whenever pain moves from a dull niggle to the kind that is difficult to ignore.

CBD oil is now legal to purchase in the UK CREDIT: PAUL GROVER FOR THE TELEGRAPH

CBD influences the release and uptake of neurotransmitters such as dopamine and serotonin, leading to many potential therapeutic uses. Crucially, it does not contain any THC, the psychoactive component of cannabis; in other words, CBD does not get you high. Since last year, it has been legal to buy in the UK, after the government’s Medicines and Healthcare Products Regulatory Agency (MHPR) approved its use as a medicine under licence.

CBD oil has since been prescribed to an 11-year-old British boy suffering from epilepsy, in what is believed to be the first instance of a cannabis-derivative being prescribed on the NHS.

Last month, a cancer patient diagnosed four years ago with an incurable brain tumour and given just six months to live, ascribed her incredible recovery to turning to cannabis oil as a last resort.

While research into the medical benefits of CBD oil is in its infancy, it is certainly encouraging. Recent reports suggest it could be a more useful anti-inflammatory than ibuprofen.

“There has been some early scientific evidence that CBD can help with inflammation,” says Dr Henry Fisher, of drug policy thinktank Volteface. “There is also a lot of anecdotal evidence that it helps people who do contact sports, because of the tendency to get inflamed joints. Taking other anti-inflammatories like ibuprofen on a long-term basis – as many sportspeople do – is not a good idea because of potential damage to your liver.”

It also has distinct advantages over opioid medicines, says Dr Fisher. “With CBD, there is no evidence of any long-term negative impact, and no likelihood of addiction. And, of course, there are no known cases of anybody overdosing on CBD.”

The comparison to prescription medicine is particularly pertinent for me. For several months after my accident, I took Oxycontin, a common opioid painkiller. It was very useful at that time because it gave me a warm fuzzy feeling, making everything seem okay. But after a while, I started waking up feeling groggy and crushed. So I decided to stop, and the withdrawal was horrendous. It was several days of indescribable misery, so bad that it made the pain from the injuries feel like a slightly over-zealous massage.

Getting off that heavy-duty medicine was key for my recovery. Because this kind of medication saps your energy, and the one thing you need to fight back to full fitness is energy. I spent months in a wheelchair, then on crutches, then finally I was able to start taking slow, painful steps on legs that had forgotten what their purpose was. I had always done a lot of sport, particularly martial arts – I got my black belt in kickboxing when I was 21 and spent some time working as an instructor. This training helped after the accident because I was in reasonably good shape – mashed bones notwithstanding – and I was used to pushing myself.

I never thought I would be able to fight again. So I just concentrated on simply being able to take care of myself. I also just got on with my life, somehow managing to acquire a lovely wife, daughter and son along the way. Then three years ago, I decided that the legs must have healed as much as they were ever going to, and I started doing martial arts again.

Thanks to CBD oil, Richard Holt can now practice Brazilian Jiu Jitsu pain-free CREDIT: ANDREW CROWLEY

Rather than risk going back to kickboxing, I took up Brazilian jiu-jitsu, a grappling discipline where you subdue your opponent with chokes and joint-locks. If you watch beginners, it can look a bit like playground wrestling, but done properly it is graceful but deadly. I started off gently, but after a while I put the injuries behind me and trained as hard as ever. It was through the men I train with that I found out about CBD.

Everyone that uses it tells a similar story: they sleep better and feel less pain. While there are ongoing trials for CBD as a treatment for everything from multiple sclerosis to Parkinson’s disease, all I know is that for me it can make the difference being sitting on the sofa and being able to go training. I can now lift and carry my children without wincing.
CBD does not make the pain go away completely, but that is okay – a bit of pain is necessary, an alarm system to warn of imminent peril. But once the message has been received, it is nice to be able to turn the volume down a little bit.

Humans have cultivated and used the flowering tops of the female cannabis plant, known colloquially as marijuana since history was recorded. Archaeologists in Central Asia even found over 2 pounds of cannabis in a 2,700-year-old grave of a shaman.

Written and pictorial evidence of cannabis use is scattered throughout numerous cultures indicating a wide acceptance and use of the plant for thousands of years.

Drug Classification Halts Use

Federal prohibitions outlawing the therapeutic and recreational use of cannabis were first imposed by Congress with the Marijuana Tax Act of 1937. Later, the plant’s organic compounds (cannabinoids) were classified as a Schedule I substance under the Controlled Substances Act of 1970.

This classification puts the plant in the same pool as heroin and states that cannabis possesses “a high potential for abuse … no currently accepted medical use … [and] a lack of accepted safety for the use of the drug … under medical supervision.”

In contrast, cocaine and methamphetamine – illegal for recreational use, may be consumed under a doctor’s supervision and are classified as Schedule II drugs. Examples of Schedule III and IV drugs include anabolic steroids and Valium. Analgesics that contain codeine are defined by law as Schedule V drugs, the most lenient classification.

In Support of Therapeutic Use

Federal lawmakers continue to use the dated drug classification as a means to defend criminalization of marijuana. However, there appears to be a very little scientific basis for the categorization of the plant. As its prohibition has passed 75 years, researchers continue to study the therapeutic properties of cannabis.

There are over 20,000 published reviews and studies in a scientific literature that pertain to the cannabis plant and its cannabinoids, almost one-third of these have been published in the last 4 years. A keyword search on PubMed Central (the US government library of peer-reviewed scientific research) shows 2,100 studies alone since 2011.

Modern culture is now catching up on what our ancestors knew, and public opinion and relaxing state legislation are leading the way for more people to use medicinal marijuana for a wide number of medical conditions. At present, marijuana for medical purposes is legal in 20 states and the District of Columbia.

While the debate continues to boil at both state and federal levels, there has been a strong and growing trend of acceptance related to the growing body of scientific evidence indicating that marijuana may indeed contain some powerful medicinal properties that we would be foolish to overlook.

Joycelyn Elders, MD, former US Surgeon General, wrote the following in a March 26, 2004, article titled “Myths About Medical Marijuana,” published in the Providence Journal:

“The evidence is overwhelming that marijuana can relieve certain types of pain, nausea, vomiting and other symptoms caused by such illnesses as multiple sclerosis, cancer, and AIDS — or by the harsh drugs sometimes used to treat them. And it can do so with remarkable safety. Indeed, marijuana is less toxic than many of the drugs that physicians prescribe every day.”

Ray Cavanaugh, Ph.D., National Director of the American Alliance for Medical Cannabis (AAMC), wrote the following in a 2002 article titled “The Plight of the Chronically Ill,” posted on the AAMC website:

“Many of the chronically ill have successfully sought relief with the use of medical cannabis, an age-old remedy that now shows real scientific efficacy. Hundreds of thousands of the sick have replaced disabling narcotics and other psychotropic medications with nontoxic and benign cannabis. The anecdotal evidence is overwhelming.

Folks with spinal injuries able to give up their walkers, AIDS patients able to gain weight and keep their medications down, cancer patients finding relief from the terrible nausea of chemotherapy, chronic pain patients once again functional with their consciousness restored from narcotic lethargy, and folks once disabled from crippling psychiatric disorders and addictions, returned to sanity and society with the assistance of a nontoxic herb with remarkable healing powers.”

The American Nurses Association (ANA) wrote the following in its Mar. 19, 2004 “Position Statement: Providing Patients Safe Access to Therapeutic Marijuana/Cannabis,” posted on the ANA website:

“The American Nurses Association (ANA) recognizes that patients should have safe access to therapeutic marijuana/cannabis. Cannabis or marijuana has been used medicinally for centuries. It has been shown to be effective in treating a wide range of symptoms and conditions.”

Researchers at the University of California Center for Medicinal Cannabis Research announced findings from a number of randomized, placebo-controlled clinical trials on the medical utility of inhaled cannabis in 2010.

The studies used the FDA ‘gold standard’ clinical trial design and reported that marijuana should be the “first line of treatment” for patients suffering from neuropathy and other serious illnesses.

Neuropathy is a type of pain associated with diabetes, cancer, spinal cord injuries, HIV/AIDS and other debilitating conditions. The trials indicated that marijuana controlled pain as good or better than available medications.

Scientists continue to study the effectiveness of cannabinoids all over the world. In Germany, there have been over 37 controlled studies, with over 2,500 subjects, assessing the safety and efficacy of marijuana, since 2005. In contrast, most FDA-approved drugs go through far fewer trials with fewer subjects but are approved for use.

The research on cannabis has shifted from studying its ability to alleviate symptoms of a disease such as nausea associated with chemotherapy to its potential role in modifying disease. Medical marijuana has been shown to slow the onset of Alzheimer’s disease and moderate autoimmune disorders including multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis.

Cannabis and Coconut Oil

Medical marijuana capsules infused in coconut oil are an alternative way to therapeutically use cannabis without having to inhale it through smoking. Infusing cannabis into coconut oil also allows for easy entry into the liver where it can be rapidly processed.

Coconut oil is used because of its high amount of essential fatty acids which makes it a good binding agent for the cannabinoids. Not to mention its amazing health properties. Half of the fat in coconut oil is comprised of a fat that is not frequently found in nature, lauric acid.

Lauric acid has been called a “miracle” ingredient due to its health-promoting capabilities and is present in a mother’s milk. In fact, it can be found in only three dietary sources—small amounts in butterfat and larger amounts in palm kernel and coconut oil.

In the body, lauric acid is converted to monolaurin, which is a potent antiviral, antibacterial and antiprotozoal substance. Because monolaurin is a monoglyceride, it can destroy lipid-coated viruses including measles, influenza, HIV, herpes and a number of pathogenic bacteria.

Testimony – A Success Story

While many remain suspicious of the therapeutic benefits of cannabis, Stan and Barb Rutner are convinced of its efficacy. This couple has stood in the face of cancer a number of times and survived to learn from their experiences.

Barb had two bouts of breast cancer and Stan were diagnosed 20 years ago with non-Hodgkin lymphoma which, after treatment, disappeared. However, in 2011, it returned. Cancerous nodes in his lungs were diagnosed and later he was told that the cancer was in his brain. The outlook was grim indeed.

As he went through the harsh treatment of chemotherapy and radiation, Stan and his family wanted to find a natural solution that would help improve his quality of life and even prolong it. Hearing that cannabis was effective in helping with the pain and other effects of chemotherapy for cancer patients they were more than open to give it a try. According to Stan and Barb, medical cannabis was the golden ticket.

The Rutners daughter, Corinne and her husband did some research and it was decided that daytime cannabis capsule infused in coconut oil would be a good choice. After two weeks of taking the capsule, Stan was able to give up his oxygen tank that he was tied to around the clock. He began to gain weight, sleep better and get stronger overall. After several months, a brain scan revealed that Stan was completely cancer free.

The Rutners are convinced that cannabis works as an anti-cancer medicine. According to John, the Rutners son-in-law:

“There is no doubt in my mind that cannabis pulled my father-in-law out of the wasting stages of cancer and enabled him to gain strength and in turn fight this horrible cell malfunction with success. While many would say that the chemo and radiation could have played a part, he would never have lived long enough to find out without cannabis oil.”

The Hearty Soul is pleased to offer our readers a FREE jar of coconut oil through Thrive Market, an online grocery store that delivers organic, healthy, non-GMO foods right to your doorstep! Take advantage of this great offer today. 


Coconut Oil and Cannabis Capsule – A Medical Miracle?

ADHD Hyperactivity, impulsiveness, mood swings, hypersensitivity, crankiness, lack of concentration and organisation, as well as difficulty falling asleep. These are the symptoms that typically determine the lives of ADHD patients. ADHD medication usually comes with a plethora of side effects. Would cannabis be an alternative?

Is cannabis a reliable alternative to conventional ADHD medication?
Hyperactivity, impulsiveness, mood swings, hypersensitivity, crankiness and aggression, lack of concentration and organisation, as well as difficulty falling asleep at night. These are the symptoms – all of them or some of them – that typically plague the lives of ADHD patients, often causing social problems in everyday life. The ADHD medication which is prescribed as a result usually causes health problems. Reason enough, it seems, to once again examine cannabis as a possible alternative.

Cannabis as a treatment for ADHD – Case studies and their results

This article will start by introducing a number of case studies into cannabis and ADHD (Attention Deficit Hyperactivity Disorder) that were conducted in the past. The research results of the latest study into the use of Sativex as a treatment for ADHD dating from 2015 are not available as yet, but Sensi Seeds will share them with you as soon as they are.

Successful cannabis treatment of therapy-resistant ADHD in adults

Adults suffering from ADHD who were therapy-resistant to conventional pharmacological treatment and who were granted permission to use cannabis flowers between 2012 and 2014 were subjected to an anonymous case study, during which the anonymised medical records of 30 adult patients were analysed. It was established that cannabis resulted in an improvement of a variety of symptoms, such as better concentration and sleep, and reduced impulsiveness.

The 28 male and 2 female patients were between the ages of 21 and 51. For 63% of them, ADHD was only first diagnosed during adulthood, while 37% was already diagnosed in childhood. The patients that were diagnosed between the ages of 6 and 13 had been treated before with methylphenidate, which is sold under the brand name Ritalin, among others. Other pharmacological therapies included atomoxetine, dexamphetamine (an active ingredient of the amphetamine class sold under the brand name Attentin), lisdexamphetamine, a synthetically-produced active stimulant ingredient of the phenethylamine class and amphetamine class, and amphetamine juice. It was established that these treatments were abandoned, mostly because of side effects and often on the grounds of insufficient effectiveness. Eight patients took stimulants in combination with cannabis, while 22 patients only used cannabis.

The conclusion of this case study was that “for adult patients with ADHD, who experience side effects or do not profit from standard medication, cannabis may be an effective and well-tolerated alternative.” Data from the study can be found on page 85 of this conference abstract.

Many people suffering from ADHD treat themselves with cannabis

People who suffer from ADHD are known to have an inclination to practice self-medication, using cannabis among other remedies. In 2012, the Psychology Department of the University of Albany in New York conducted a study in which data was evaluated from a subgroup of individuals suffering from ADHD who self-medicated with cannabis.  The data of 2811 ADHD patients was analysed, originating from a survey among American cannabis users.
What is meant by ‘subgroup’ in this context? Typically, there are three different ADHD subgroups:

  • ‘Fidgety Philip’, mostly hyperactive and impulsive;
  • ‘Johnny Head-in-the-Clouds’, mostly attention deficient;
  • Mixed type: both attention deficient and hyperactive.

The patients were asked about their symptoms when not using cannabis. It was established that the majority of daily consumers satisfied the criteria that comprise the hyperactive-impulsive pathology clinical picture.  For the non-daily consumers, there was no difference between them and consumers with ADHD from the hyperactive and attention deficient subgroups. The researchers concluded that “these results have implications for identifying which individuals with ADHD might be more likely to self-medicate using cannabis.” In addition, the scientists made it clear that said results support further research into the relation between cannabinoid receptors and regulatory control.

Positive effect of moderate cannabis on cocaine-addicted ADHD patients

The New York State Psychiatric Institute discovered in a study conducted in 2006 among 92 cocaine-addicted ADHD patients that moderate cannabis use can have a positive effect on abstaining from cocaine use. The study was held among adults in the age group of 25 to 51, the majority (69%) of whom used cannabis. The patients subjected themselves to a treatment with methylphenidate for their ADHD and cocaine addiction. The effect of cannabis on continuing the therapy and abstaining from cocaine was studied.

57% of the patients who consumed cannabis moderately were still part of the patient group after 14 weeks of treatment. Of the patients who did not use cannabis, only 24% was still part of the group by week 14, compared with 39% of the regular/strong cannabis users.

Furthermore, the consumption of cannabis resulted in greater cocaine abstinence. Of the patients who indicated intermittent cannabis use, 39% had abstained from using cocaine for two or more weeks, compared to 26% of those who indicated not having used cannabis during the treatment.

Cannabis can have a positive effect on adolescents with ADHD

In a study conducted in 2008 in Nottingham, the United Kingdom, scientists observed that adolescents with ADHD who used cannabis showed a trend towards a decline in disorganisation, hyperactivity and lack of attention. The study was conducted with a patient group of 25 individuals and showed that cannabis can have a positive effect.

Tourette’s Syndrome and ADHD – improvement with cannabis

German scientists, while treating a 15-year old with Tourette’s Syndrome and ADHD in 2010, discovered that THC caused a significant improvement in terms of the spasmodic tics without causing side-effects, which, in turn, made it possible to treat his ADHD symptoms with stimulants. The following was concluded: “Our observation suggests that Delta 9-THC might be a successful alternative in patients with severe TS refractory to classic treatment. Particularly in the case of stimulant-induced exacerbation of tics, Delta 9-THC might enable successful treatment of comorbid ADHD.” However, more research is needed to substantiate these findings.

Cannabis vs. stimulant drugs

What can be agreeable and effective ADHD medication, or reasonably so, for one person, can have no effect or the wrong effect on another individual; or it has so many side-effects that its use has to be discontinued. Ritalin is a good example to show what pharmaceutical ADHD prescription drugs are all about.

What is Ritalin?

Ritalin is a good example to show what pharmaceutical ADHD prescription drugs are all about.
Ritalin is a central nervous system stimulant and a derivative of the amphetamines class of drugs. These have special pharmaceutical significance, as new and more effective medication can be manufactured from derivatives of existing drugs.

Methylphenidate (in short: MPH) was synthesized for the first time in 1994 and is mainly used as a medicinal treatment for ADD, ADHD and narcolepsy.

In most countries, Ritalin is a prescription drug subject to specific prescription requirements.

How does Ritalin work?

Methylphenidate stimulates and excites. It suppresses tiredness and inhibitions, increases short-term physical performance and inhibits appetite. Furthermore, it restricts the function of the transporters of the dopamine and noradrenalin neurotransmitters. In terms of this property it is similar to cocaine.

Side-effects of Ritalin use

Long-term use of Ritalin by children can lead to reduced growth and weight gain. Appetite and liquid intake may be inhibited. Furthermore, nausea, burning in the oesophagus, belly ache and vomiting can occur. Other reported side-effects are increased sweating, dermatitis, itching and hair loss. Also, taking Ritalin can lead to sleep disorders and sleeplessness, nervousness, headaches, anxiety, depressed mood and depression, restlessness, agitation, aggression, stress, dizziness, disorientation, emotional instability, tachycardia and cardiac dysrhythmia.

A large overdose of Ritalin can result in over-stimulation of the central nervous system, cramps, delirium, and even coma.

Finally, as the effect of Ritalin intake begins to wear off, the original symptoms may worsen significantly, including unwanted behaviour. This is called the rebound effect.

Ritalin criticised

The global independent Cochrane Collaboration network has closely examined ADHD medication such as Ritalin and recently concluded that

  • the effectiveness of Ritalin and other similar stimulants is only moderate; and
  • the quality of the studies into the deployment of these ADHD drugs is unsatisfactory.

It summarizes: “Although Ritalin has been prescribed for over 50 years, as yet no comprehensive, systematic and therefore scientifically reliable studies into its benefits and dangers have been conducted, as with other psychotropic drugs.”

Rather cannabis, then?

Consuming medicinal cannabis seems to be an obvious treatment for ADHD symptoms. THC and CBD are known to have an anti-depressive anxiety reducing effect. Cannabis relaxes the user and gives them a sense of tranquillity. Hyperactivity, fear and anxiety are reduced. Furthermore, ADHD patients often report that cannabis helps them to unwind and fall asleep at night.

Also, cannabis helps to reduce symptoms such as mood swings, lack of attention and irritability in individuals suffering from neuro-psychiatric disorders such as ADHD.

ADHD rarely in isolation – associated disorders

For many ADHD patients, attention deficit and/or hyperactivity are/is not the only symptom(s) they suffer from. A closer look reveals that bipolar disorders, depression, compulsive behaviour, social behaviour disorders, anxiety, sleep and obsessive-compulsive disorders, as well as illicit drug abuse, often accompany ADHD.

Dopamine: The happiness hormone and illicit drugs

The tendency towards drug abuse among ADHD patients can be explained by low levels of dopamine (the happiness hormone) in their bodies.

Many recreational drugs, such as alcohol, tobacco, cocaine and cannabis, cause an increase in the user’s dopamine level. However, cannabis only has a relatively mild influence on dopamine, which could explain the substance’s low level of dependency potential.

Yes, cannabis use causes a slight increase in the dopamine level. This happens because it cooperates with the dopamine binding sites that can be found on several neurons in the brain. Prescription drugs such as Ritalin work identically.

“Cannabis appears to treat ADD and ADHD by increasing the availability of dopamine. This then has the same effect but is a different mechanism of action than stimulants like Ritalin (methylphenidate) and dexedrine amphetamine, which act by binding to the dopamine and interfering with the metabolic breakdown of dopamine.” – Dr David Bearman, M.D.

The importance of the endocannabinoid system

It is the endocannabinoid system that influences the dopamine level. This interdependence seems to have been altered in ADHD patients. The level of anandamide, a cannabinoid that occurs naturally in the human body, is higher in individuals who suffer from ADHD.

The endogenous substance anandamide, which is produced by the body itself, binds to the cannabinoids receptors of the endocannabinoid system, to which THC binds as well. From this, it follows that the human body is capable of producing more endocannabinoids in a natural way to combat the symptoms of ADHD. Therefore, scientists are convinced that the endocannabinoid system is crucial to the treatment of ADHD. Sensi Seeds has already reported this significance in a previous article.

It was established that the correct functioning of the endocannabinoid anandamide and 2-AG, as well as of the corresponding cannabinoids receptors themselves, is essential for the normal cognitive and psychomotor development of children during growth. The correct functioning of the endocannabinoid system in relation to impulsive behaviour represents a finely attuned and complex system, and disruptions in this careful balance may result in disorders such as ADHD. Italian and American scientists concluded from the studies they conducted in 2011 that “therapeutic strategies that aim to influence the endocannabinoid system might be effective as a treatment for this disorder.”

Cannabinoid receptors can be found in higher concentrations in those parts of the brain that are being associated with the symptoms of ADHD, especially the hippocampus and the amygdala. The amygdala is involved in the development of fear, and plays an important role in emotionally evaluating, recognising situations and analysing possible dangers. It processes external impulses and launches the vegetative reactions to them. The role of the hippocampus is to code information that enters the body from the outside.

Reports from patients and physicians about the deployment of cannabis for ADHD

Below we have provided a few quotes on the use of cannabis as a treatment for children, adolescents and adults with ADHD, both as alternative and complementary medication:

“[From prescribed stimulant medications] I remember having headaches all the time to the point where I wasn’t able to sleep.” Also, Antonio had very poor appetite. With cannabis, things have improved somewhat. The side-effects of the stimulants became less severe and his ADHD symptoms were noticeably reduced. “For the first time ever, I was in the state where I could really get my mind together.” – Antonio Rodriguez (Cannabis and ADD/ADHD)

“It helps combat the problems with falling asleep as a result of methylphenidate use (Mediket) and depression. Thanks to cannabis, I can be calmer even without Mediket. My social environment and family in particular benefit from that. It allows me to wind down, despite Mediket and ADHD. It diminishes the hyperactivity and hurriedness as a result of Mediket and ADHD. It can compensate the ADHD-induced lack of focus in certain situations better than Mediket can. It enables me to introduce Mediket-free periods in order to not feel like a live wire every now and then. It makes me placid and less hurried.” – Maximilian Plenert (How does cannabis help with ADHD?)

“Almost all patients that use cannabis therapeutically report that it helps them to pay attention during lectures and to be able to better concentrate instead of thinking about various things simultaneously. Furthermore, it helps them to keep up with their assignments and do their homework.” – David Bearman, M.D., physician and cannabinoidologist

“The only thing that I could always count on to help me over the past 22 years [of ADHD] has been cannabis. It helps me to find inner calm. I am not aggressive, but friendly and sociable. Without cannabis I am a devil and the pain increases.” – Ralf Hermann (ADHD and cannabis – a portrait)

“Cannabinoids are a totally viable alternative for treating adolescents suffering from ADD and ADHD. …Why would anyone give their child an expensive pill… with unacceptable side-effects when you could go out into the garden, pluck a few leaves from a plant and brew him or her a nice cup of tea instead?” – Dr Claudia Jensen, paediatrician and clinical instructor at the University of Southern California.

“My ADHD was either not treated or was treated incorrectly. From childhood, I was prescribed drops and tablets which were discontinued when I was 13 years old because everything would right itself during adolescence. The consequences: inability to pay attention, 1,000 thoughts in my head, quick to become irritable, aggression and poor concentration! Shortly afterwards, I tried cannabis for the first time and noticed that I was able to concentrate and thus complete my secondary school education…” – Chris Vrzak (Cannabis: a plant with many faces)

“While some apply preconceptions that marijuana exacerbates ADHD, almost all California cannabinologists believe cannabis and cannabinoids have substantially improved the lives of ADHD sufferers, and with less negative side effects than common stimulant drug ADHD treatments.” – David Bearman, M.D.


Although case studies into the deployment of medicinal cannabis for the treatment of ADHD exist, more scientific substantiation of the results obtained so far is required. However, the justice system is obstructing scientific research into the use of medicinal cannabis for the treatment of ADHD.
In the current medical climate, cannabis is not yet taken seriously. Education and perseverance are needed to make the medical fraternity realise that cannabis is a real and viable alternative. Sensi Seeds will remain vigilant.


While the FDA pushes for a ban on kratom, a group of scientists is arguing that if it is labeled as a Schedule I drug, opioid-overdose deaths will only continue to increase.

The United States Food and Drug Administration ramped up its “War on Kratom” this week by labeling the natural herb as an opioid, and a group of scientists is stepping up to vouch for kratom’s safety, and to argue that banning it would only lead to more opioid-related deaths.

In a statement, FDA Commissioner Scott Gottlieb warned that there is even stronger evidence of kratom compounds’ opioid properties.” He claimed that there is evidence of 36 deaths related to kratom, but that “many of the cases received could not be fully assessed because of limited information provided.”

In response, a group of scientists came together to send a letter to the acting administrator of the Drug Enforcement Administration, Robert Patterson; and the counselor to the president who is overseeing the administration’s response to the opioid crisis, Kellyanne Conway.

The letter strongly criticized the FDA’s recommendation to label kratom as a Schedule I drug, which would mean that the government will claim that it has no medicinal value.

We believe strongly that the current body of credible research on the actual effects of kratom demonstrates that it is not dangerously addictive, nor is it similar to ‘narcotics like opioids’ with respect to ‘addiction’ and ‘death’ as stated by the FDA in its November 14th Kratom Advisory. Equally important, four surveys indicate that kratom is presently serving as a lifeline away from strong, often dangerous opioids for many of the several million Americans who use kratom. A ban on kratom that would be imposed by CSA Scheduling would put them at risk of relapse to opioid use with the potential consequence of overdose death. Similar unintended consequences are to be expected in some who would be forced to use opioids to manage acute or chronic pain.”

The scientists noted that when kratom is consumed in raw plant form, “it does not appear to produce the highly addictive euphoria or lethal respiratory depressing effects of classical opioids.” In fact, they argued that labeling kratom as a Schedule I drug would actually increase the number of opioid-related deaths in the United States.

“It is our collective judgment that placing kratom into Schedule I will potentially increase the number of deaths of Americans caused by opioids because many people who have found kratom to be their lifeline away from strong opioids will be vulnerable to resumption of that opioid use, whether their prior opioid use was for relief of pain or due to opioid addiction,” the scientists wrote.

The letter cited several national surveys and a wealth of studies from both the U.S. and Asia, which found that “kratom has been used as a safer alternative to opioids for more than a century,” and if the government truly cared about the safety of the consumer, they would refrain from making kratom a Schedule I drug.

Although the FDA is claiming that kratom is responsible for at least 44 deaths, that is nothing when compared to the number of deaths that have occurred from opioid overdoses in recent years. As President Trump noted at his first State of the Union address, “In 2016, we lost 64,000 Americans to drug overdoses: 174 deaths per day. Seven per hour.”

However, the scientists questioned whether the FDA could actually prove that the deaths it cited were related to kratom overdoses. They noted that while opioid overdose deaths result from respiratory depression and death at high doses, the deaths the FDA claims are from kratom overdoses include “a wide variety of apparent causes in people suffering from various diseases and/or taking other substances that also likely contributed to their deaths.”

Why is the FDA pushing to ban kratom when research has shown that not only is it a safer alternative to opioids, but that it actually helps to prevent opioid-overdose deaths?

As The Free Thought Project has reported, by pushing for a ban on kratom, the FDA is ensuring that Big Pharma will have a lifetime of profit, and the commissioner of the FDA is directly responsible:

Before taking over the FDA and using his position to enrich his fellow legal drug dealers, Gottlieb was a member of GlaxoSmithKline’s product investment board. And, as TFTP has previously reported GlaxoSmithKline owns a patent on a kratom alkaloid designed for the very purpose of treating pain, thereby alleviating dependency on opioids. One of Kratom’s alkaloids—Speciofoline—was researched decades ago by Gottlieb’s former employer and its effects have been widely studied and reported on.

It just so happens that a patent was filed for Speciofoline on August 10, 1964. The patent claims the “alkaloid has useful pharmacodynamic activity, particularly analgetic and antitussive activity.” But that’s not all. Other studies—which the FDA says do not exist—have been conducted for the specific task of treating opioid dependency.

The moment medical marijuana has been waiting for since California first passed laws legalizing the medicinal use of cannabis, in 1996, is finally here — the US government has, at last, admitted that marijuana has medical benefit. Yes, you heard right — the US government recently updated content pages on the National Cancer Institute’s (an official division of the US Department of Health) website to include information about, cannabis and cannabinoids.

Attempting to not draw too much attention to the update, the US National Cancer Institute quietly updated their website in January, admitting that cannabis and cannabinoids kill cancer without damaging the body’s normal cells. Considering that cannabis is a Schedule 1 drug, which according to the Controlled Substances Act of 1970, means that it holds NO MEDICINAL VALUE, how could such a unbelievable admission go unnoticed by mainstream media? After all this is the plant that has been demonized as the “gateway drug”, for the past 80 years — this is BREAKING NEWS!!

The pages include a section for both patients, and physicians, and covers topics ranging from the medical effects of cannabinoids, to preclinical studies conducted using cannabis or cannabinoids. Studies in mice and rats have shown that cannabinoids may inhibit the growth of a tumor by causing cell death, blocking cell growth, and blocking the development of blood vessels need by tumors to grow. While further animal and laboratory study’s have shown evidence that cannabinoids may be able to kill cancer cells while protecting normal cells.

Additional studies have shown that there is evidence of cannabinoids protecting against inflammation and cancer of the colon; may have anti-tumor effects; may be effective in stoping breast cancer; and may make chemotherapy more effective.

Also included, is commentary about how the US government distributed cannabis to patients on a case-by-case basis under the Compassionate Use Investigational Drug (IND) program between 1978 and 1992, despite while claiming that cannabis held no medicinal value. It goes on further to say that researchers, have studied how cannabinoids act on the brain and other parts of the body, and have discovered cannabinoid receptors (molecules that bind cannabinoids) in both brain cells, and nerve cells in other parts of the body, with further evidence of cannabinoid receptors on immune system cells, suggesting that cannabinoids may play a key role in immunity, too.

It also includes information on its effectiveness to stimulate an appetite, relieve pain, reduce inflammation, control nausea and vomiting, it’s anti-anxiety effects.

Since the early 1990’s physicians have been prescribing opioid medications at an ever-increasing, and alarming rate. Resulting in an epidemic far greater in evil, than any reefer madness. The US, is now battling to counter the out-of-control, critical state of prescription drug abuse that is plaguing all classes, ethnicities, and ages. It is estimated that 52 million people have used prescription pills for non-medical reasons at least once in their lifetime, including a overwhelming large number of young people. The National Institute on Drug Abuse (NIDA) conducted a survey called “Monitoring the Future”, which found that 1 in 12 high school seniors reported non-medical use and abuse of prescription pills, while rating Vicodin, and OxyContin, as the most commonly abused drugs by adolescents. In an effort to regain control of the pill-popping monster that has been pharmaceutically created, the US is clamping down on the physicians who have writing the prescriptions, enforcing a strict new protocol that is leaving only pain management physicians with the right to prescribe pain pills.

Which leaves us to wonder only one thing – could the federal government be getting ready to reschedule cannabis, allowing for the medical research and scientific study of pot?

Firstly as a solution, to curbing the pandemic of prescription abuse among people, and patients. Secondly as a peace offering, to the pharmaceutical super-giants grotesquely over-capitalizing on the current state of the nation — cannabis will open the door to a whole new pharmaceutical industry as compensation, and while this is not something we condone, the simple fact alone is enough to have the ensure that pharmaceutical lobbyists share our agenda. Thirdly, because President Obama promised to support and sign the CARERS ACT, legalizing the medicinal use of marijuana thereby allowing for its use by the Veterans Affairs, and the vets who repeatedly keep pleading for reform — Question: Why are our vets pleading? They are our veterans, the men and women who have risked their lives, to defend and protect ours. They shouldn’t need to ask – let alone still beg or plead! As a nation, we should respectfully give them anything they need to help ease their pain and suffering, as a result of their service.

And finally – and most importantly of all – because President Obama promised change, and congressional reform of medical cannabis if the states led the way. Considering that when Obama took office in 2009 there were already 14 legal medical marijuana states, and now there’s 23 with more on the way, while 4 states and the District of Columbia have altogether legalized the recreational adult-use of pot, its clear that the states have held up their end. Now, its time for the president to uphold his.

“I don’t think rescheduling is something that I would characterize as drastic,” said U.S. Rep. Earl Blumenauer (D-Oregon), one of the key members of Congress’s cannabis reform cabal. “If we were scheduling today, marijuana would not be Schedule I — or Schedule II. In fact, it may not be scheduled at all.”

“If we were scheduling from scratch and doing so based on scientific evidence, tobacco would be Schedule I. It’s an addictive killer,” he added

In support of medicla marijuana and it’s patients, everywhere:
PLEASE SHARE THIS BREAKING NEWS with as many people in your network, as you can. Help stop reefer maddness once and for all, and spread the word that the federal government has admitted the truth, about marijuana and its medicincal value. 
Help PUSH President Obama to keep his promise and reschedule cannabis, for the greater good of us all!!


Click Only Like Page Button OR Cross Button